Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - CASH FROM OPERATIONS
Cash from Operations GERN - Geron Corporation
-168 M
LAST VALUE
-32.49%
2 YEAR CAGR
-51.51%
5 YEAR CAGR
-16.42%
10 YEAR CAGR